<html>
<head>PUBMED IDs for Z23</head>
<body bgcolor='#C5F0F2'><h1>Z23</h1><a href='https://pubmed.ncbi.nlm.nih.gov/2446266/'>Isolation and mapping of a polymorphic DNA sequence pYNZ23 to chromosome 1 (DIS58).</a> November 25  1987<br><a href='https://pubmed.ncbi.nlm.nih.gov/17270230/'>Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells.</a> February 3  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19029981/'>Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19366795/'>PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.</a> July 15  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19671762/'>NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas.</a> January 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19789349/'>Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.</a> December 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19965685/'>Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia.</a> February 24  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20022807/'>Identification of prophage gene z2389 in Escherichia coli EDL933 encoding a DNA cytosine methyltransferase for full protection of NotI sites.</a> August 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20022769/'>Cardiac calcitonin gene-related peptide and left ventricular hypertrophy in the cardiac allograft.</a> July 7  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20499346/'>NVP-BEZ235, a dual pan class I PI3 kinase and mTOR inhibitor, promotes osteogenic differentiation in human mesenchymal stromal cells.</a> February 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20581867/'>H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3.</a> September 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21057530/'>Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo.</a> May 20  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21062981/'>Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.</a> February 8  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21498705/'>The dual PI3K/mTOR inhibitor BEZ235 is effective in lung cancer cell lines.</a> June 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21633166/'>Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.</a> October 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21646547/'>Levels of p27 sensitize to dual PI3K/mTOR inhibition.</a> December 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21876152/'>PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis.</a> November 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21930930/'>Aberrant AKT activation drives well-differentiated liposarcoma.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22009179/'>Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cells.</a> June 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22009167/'>Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis.</a> May 9  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22218692/'>Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastoma.</a> May 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22438255/'>Cotargeting signaling pathways driving survival and cell cycle circumvents resistance to Kit inhibitors in leukemia.</a> July 18  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22488590/'>Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells.</a> November 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22539746/'>mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.</a> October 20  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22543857/'>Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines.</a> August 4  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22692904/'>Secretin receptor promotes the proliferation of endocrine tumor cells via the PI3K/AKT pathway.</a> December 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22692893/'>Null genotypes at the GSTM1 and GSTT1 genes and the risk of benign prostatic hyperplasia: a case-control study and a meta-analysis.</a> February 27  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23012248/'>Targeting KRAS-mutant non-small cell lung cancer with the Hsp90 inhibitor ganetespib.</a> August 29  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23086777/'>Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.</a> January 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23200668/'>Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.</a> November 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23243017/'>Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.</a> April 16  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23243014/'>BMP system expression in GCs from polycystic ovary syndrome women and the in vitro effects of BMP4, BMP6, and BMP7 on GC steroidogenesis.</a> April 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23319394/'>The novel phosphoinositide 3-kinase-mammalian target of rapamycin inhibitor, BEZ235, circumvents erlotinib resistance of epidermal growth factor receptor mutant lung cancer cells triggered by hepatocyte growth factor.</a> July 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23403624/'>Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas.</a> July 3  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23475782/'>Coexistent mutations of KRAS and PIK3CA affect the efficacy of NVP-BEZ235, a dual PI3K/MTOR inhibitor, in regulating the PI3K/MTOR pathway in colorectal cancer.</a> August 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23475776/'>Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-α. Prospective clinical trial.</a> March 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23629727/'>Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.</a> November 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23935891/'>Genotype directed therapy in murine mismatch repair deficient tumors.</a> March 7  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24041865/'>Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.</a> February 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24133218/'>Pan-mammalian target of rapamycin (mTOR) inhibitor AZD8055 primes rhabdomyosarcoma cells for ABT-737-induced apoptosis by down-regulating Mcl-1 protein.</a> February 14  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24349524/'>Inhibition of PI3K/mTOR overcomes nilotinib resistance in BCR-ABL1 positive leukemia cells through translational down-regulation of MDM2.</a> September 30  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24349516/'>Autophagy in the human placenta throughout gestation.</a> September 30  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24391509/'>NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas.</a> June 18  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24448243/'>FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway.</a> May 9  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24552895/'>Dual inhibition of phosphatidylinositol 3'-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach for mucinous adenocarcinoma of the ovary.</a> February 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24652480/'>NVP-BEZ235, a dual PI3K/mTOR inhibitor, induces cell death through alternate routes in prostate cancer cells depending on the PTEN genotype.</a> November 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24650799/'>PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced.</a> July 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24927217/'>The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma.</a> February 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24927198/'>Long-term exposure to low-level arsenic in drinking water and diabetes incidence: a prospective study of the diet, cancer and health cohort.</a> July 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24927197/'>Systemic sclerosis immunoglobulin induces growth and a pro-fibrotic state in vascular smooth muscle cells through the epidermal growth factor receptor.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24969552/'>NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells.</a> February 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24969551/'>Cardiovascular risk factors and adipocytokines levels after two hypocaloric diets with different fat distribution in obese subjects and rs6923761 gene variant of glucagon-like peptide 1 receptor.</a> July 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25144531/'>Deciphering combinations of PI3K/AKT/mTOR pathway drugs augmenting anti-angiogenic efficacy in vivo.</a> May 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25216518/'>Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma.</a> June 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25275595/'>Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma.</a> July 8  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25485910/'>Mutations in G protein β subunits promote transformation and kinase inhibitor resistance.</a> March 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25590803/'>MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies.</a> September 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25622896/'>Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells.</a> September 24  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25673820/'>Dual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2.</a> January 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25762617/'>Inhibition of DNA methyltransferase as a novel therapeutic strategy to overcome acquired resistance to dual PI3K/mTOR inhibitors.</a> January 20  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25793663/'>Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.</a> January 21  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25909167/'>High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy.</a> March 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25963317/'>Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model.</a> March 22  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25963309/'>Hyperemesis gravidarum and risk of cancer in offspring, a Scandinavian registry-based nested case-control study.</a> February 6  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26013318/'>Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations.</a> May 6  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26080839/'>Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.</a> October 26  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26216950/'>Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations.</a> November 11  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26219899/'>CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.</a> February 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26337467/'>Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26337460/'>MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.</a> May 14  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26336820/'>PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.</a> August 11  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26427150/'>Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells.</a> October 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26571380/'>Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures.</a> June 24  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26678268/'>Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers.</a> June 29  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27176231/'>Effects of NVP-BEZ235 on the proliferation, migration, apoptosis and autophagy in HT-29 human colorectal adenocarcinoma cells.</a> March 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27379831/'>Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma.</a> July 6  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27438153/'>Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors.</a> July 21  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27737796/'>Strong synergism between small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 in human breast cancer cells.</a> October 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28042875/'>The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia.</a> January 3  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28184015/'>Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.</a> February 12  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28445155/'>Retinoblastoma cells activate the AKT pathway and are vulnerable to the PI3K/mTOR inhibitor NVP-BEZ235.</a> April 27  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28459209/'>Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.</a> June 8  2017<br></body></html>
